Cargando…
Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward
BACKGROUND: Dissemination bias occurs when only some results emerging from clinical research reach their intended audience in the knowledge translation process. Given that coverage decisions increasingly rely on evidence, it is important to explore the types of evidence considered. This paper aimed...
Autores principales: | Panteli, Dimitra, Nolting, Alexandra, Eckhardt, Helene, Kulig, Michael, Busse, Reinhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727332/ https://www.ncbi.nlm.nih.gov/pubmed/26813738 http://dx.doi.org/10.1186/s12961-016-0080-9 |
Ejemplares similares
-
From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries
por: Panteli, Dimitra, et al.
Publicado: (2015) -
A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe()
por: Berger, Elke, et al.
Publicado: (2022) -
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
por: Vogler, Sabine, et al.
Publicado: (2021) -
Health care patterns and policies in 18 European countries during the first wave of the COVID-19 pandemic: an observational study
por: Panteli, Dimitra, et al.
Publicado: (2022) -
Zofenopril and incidence of cough: a review of published and unpublished data
por: Omboni, Stefano, et al.
Publicado: (2011)